Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Transl Psychiatry. 2020 Jan 16;10(1):5. doi: 10.1038/s41398-020-0708-y.
Schizophrenia (SCZ) is a highly heritable psychiatric disorder that affects approximately 1% of population around the world. However, early relevant studies did not reach clear conclusions of the genetic mechanisms of SCZ, suggesting that additional susceptibility loci that exert significant influence on SCZ are yet to be revealed. So, in order to identify novel susceptibility genes that account for the genetic risk of SCZ, we performed a systematic family-based study using whole exome sequencing (WES) in 65 Han Chinese families. The analysis of 51 SCZ trios with both unaffected parents identified 22 exonic and 1 splice-site de novo mutations (DNMs) on a total of 23 genes, and showed that 12 genes carried rare protein-altering compound heterozygous mutations in more than one trio. In addition, we identified 26 exonic or splice-site single nucleotide polymorphisms (SNPs) on 18 genes with nominal significance (P < 5 × 10) using a transmission disequilibrium test (TDT) in all the families. Moreover, TDT result confirmed a SCZ susceptibility locus on 3p21.1, encompassing the multigenetic region NEK4-ITIH1-ITIH3-ITIH4. Through several different strategies to predict the potential pathogenic genes in silico, we revealed 4 previous discovered susceptibility genes (TSNARE1, PBRM1, STAB1 and OLIG2) and 4 novel susceptibility loci (PSEN1, TLR5, MGAT5B and SSPO) in Han Chinese SCZ patients. In summary, we identified a list of putative candidate genes for SCZ using a family-based WES approach, thus improving our understanding of the pathology of SCZ and providing critical clues to future functional validation.
精神分裂症 (SCZ) 是一种高度遗传性的精神疾病,影响着全球约 1%的人口。然而,早期相关研究并未得出 SCZ 遗传机制的明确结论,这表明还有其他对 SCZ 有重大影响的易感基因尚未被揭示。因此,为了确定导致 SCZ 遗传风险的新的易感基因,我们使用全外显子组测序 (WES) 在 65 个汉族家庭中进行了一项系统的基于家庭的研究。对 51 个具有未受影响父母的 SCZ 三亲体的分析确定了 23 个基因上共 22 个外显子和 1 个剪接位点的新生突变 (DNM),并且表明 12 个基因在超过一个三亲体中携带罕见的蛋白改变的复合杂合突变。此外,我们使用所有家庭的传递不平衡测试 (TDT) 确定了 18 个基因上的 26 个外显子或剪接位点单核苷酸多态性 (SNP) 具有名义意义 (P < 5 × 10)。此外,TDT 结果证实了 3p21.1 上的一个 SCZ 易感位点,包含多基因区域 NEK4-ITIH1-ITIH3-ITIH4。通过几种不同的策略在计算机上预测潜在的致病基因,我们揭示了 4 个先前发现的易感基因 (TSNARE1、PBRM1、STAB1 和 OLIG2) 和 4 个新的易感基因座 (PSEN1、TLR5、MGAT5B 和 SSPO) 在汉族 SCZ 患者中。总之,我们使用基于家庭的 WES 方法鉴定了一组可能的 SCZ 候选基因,从而提高了我们对 SCZ 病理学的认识,并为未来的功能验证提供了关键线索。